Abiopharma

Pulse Biosciences Selected to Present Late-Breaking Data from the nPulse Cardiac Catheter Study at the AF Symposium

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

BioCryst to Present at 44th Annual J.P. Morgan Healthcare Conference

Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5

Compass Pathways - Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360

Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360

New Form RW - Scilex Holding Co Filed: 2026-01-06 AccNo: 0001193125-26-003394 Size: 9 KB

New Form QUALIF - Dare Bioscience, Inc. Filed: 2026-01-05 AccNo: 9999999994-26-000005 Size: 1 KB

BioNTech SE (BNTX) Files Form 6-K

(99% Neutral) GERON CORP (GERN) Reports Q1 2026 Financial Results

CureVac (CVAC) Files Form 6-K

Apogee Therapeutics Announces Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777), its Potentially Best-in-Class Anti-IL-13 Antibody, in Patients with Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook

Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data

AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

Grey symbol attribute type Security_Name was changed. Previous value: RZOLV TECHNOLOGIES INC. New value: HISTOGEN INC.